Keros Therapeutics, Inc.

KROS · XNAS

CIK 1664710fmd_1HPRBJZQA2STSE1RKTHBKW05ZQManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 31 periods

Ratios computed from the standardized statements. Select a value to open its proof.